Palatin Technologies (PTN) Price to Earnings (2010 - 2026)
Palatin Technologies' (PTN) quarterly Price to Earnings came in at 47.56 in Q1 2026, down 1388.77% on a YoY basis from 3.69 in Q1 2025, and down 784.38% quarter-over-quarter from 5.38 in Q4 2025.
Powered by 
Analysis
Palatin Technologies (PTN) Price to Earnings (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Price to Earnings for 17 consecutive years, with 47.56 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Price to Earnings fell 1388.77% year-over-year to 47.56; the trailing twelve-month figure through Mar 2026 stood at 10.88 (down 1559.53% YoY), and the FY2025 full-year result was 5.94, up 87.66% from the prior year.
- Price to Earnings eased to 47.56 in Q1 2026 per PTN's latest filing, from 5.38 in the prior quarter.
- Across five years, Price to Earnings topped out at 1.65 in Q3 2025 and bottomed at 17462.93 in Q1 2022.
- Historically, Price to Earnings has averaged 2587.79 across 5 years, with a median of 173.68 in 2024.
- The sharpest annual moves came in 2025 and 2026: Price to Earnings soared 101.46% in 2025, then slumped 1388.77% in 2026.
- Over 5 years, Price to Earnings stood at 4466.21 in 2022, then surged by 91.87% to 362.92 in 2023, then sank by 38.71% to 503.39 in 2024, then surged by 98.93% to 5.38 in 2025, then sank by 784.38% to 47.56 in 2026.
- According to Business Quant data, Price to Earnings over the past three periods registered 47.56, 5.38, and 1.65 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -47.56 |
| Dec 31, 2025 | -5.38 |
| Sep 30, 2025 | 1.65 |
| Jun 30, 2025 | -1.64 |
| Mar 31, 2025 | -3.19 |
| Dec 31, 2024 | -503.39 |
| Sep 30, 2024 | -113.09 |
| Jun 30, 2024 | -173.68 |
| Mar 31, 2024 | -158.56 |
| Dec 31, 2023 | -362.92 |
| Sep 30, 2023 | -149.13 |
| Jun 30, 2023 | -2,607.22 |
| Mar 31, 2023 | -3,676.05 |
| Dec 31, 2022 | -4,466.21 |
| Sep 30, 2022 | -7,909.47 |
| Jun 30, 2022 | -6,353.63 |
| Mar 31, 2022 | -17,462.93 |
| Dec 31, 2021 | -17,004.10 |
| Sep 30, 2021 | -17,619.99 |
| Jun 30, 2021 | 63,003.16 |